LPCN · Lipocine Inc.
$2.11
+0.05 (+2.43%)
At close · Aug 14
Market Cap
$17.40M
Shares
8.24M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-04 | — | |
| 10-Q | 2026-08-04 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-06-12 | — | |
| 8-K | 2026-06-04 | — | |
| 8-K | 2026-06-04 | 2026-06-03 | |
| 8-K | 2026-05-26 | — | |
| 8-K | 2026-05-19 | — | |
| 8-K | 2026-05-18 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| 8-K | 2026-04-21 | 2026-04-16 | |
| DEF 14A | 2026-04-21 | — | |
| 8-K | 2026-04-02 | — | |
| 8-K | 2026-04-02 | — | |
| 10-K | 2026-03-10 | 2025-12-31 | |
| 8-K | 2026-03-10 | — | |
| 8-K | 2026-03-04 | 2026-02-26 | |
| 8-K | 2026-02-18 | — | |
| 8-K | 2026-02-18 | — | |
| 8-K | 2026-01-20 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-16 | 2025-12-15 | |
| 8-K | 2025-12-15 | 2025-12-12 | |
| 8-K | 2025-12-11 | 2025-12-08 | |
| 8-K | 2025-11-18 | — | |
| 8-K | 2025-11-18 | — | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-09-30 | — | |
| 8-K | 2025-09-26 | — | |
| 8-K | 2025-09-05 | — | |
| 8-K | 2025-09-05 | — | |
| 8-K | 2025-08-26 | — | |
| 8-K | 2025-08-05 | — | |
| 10-Q | 2025-08-05 | 2025-06-30 | |
| 8-K | 2025-07-09 | — | |
| 8-K | 2025-07-02 | — | |
| 8-K | 2025-06-26 | — | |
| 8-K | 2025-06-23 | — | |
| 8-K | 2025-06-09 | — | |
| 8-K | 2025-06-04 | — | |
| 8-K | 2025-05-22 | — | |
| 8-K | 2025-05-14 | — | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| 8-K | 2025-05-08 | — |
Showing 1–50 of 258 filings
Key facts
CIK
1535955
CUSIP
53630X203
13F (30d)
35 filings
34 filers
Visit website
Investor relations